Celebrating its 18th year of helping its members outperform the market
|Richmond Club Index||TSX Venture||S&P 500||Theoretical Richmond|
Fund 1% MER
20.34% annualized performance since inception in July 2005
The Richmond Club is celebrating its 17th year of helping its members outperform the market by providing them with ongoing information about the undervalued companies with excellent growth potential that Greg Beckett, CIM, FCSI has selected for the Richmond Index. To be invited to future luncheon events and to receive a link to the latest CEO presentations, please email us your coordinates.
To be selected for inclusion in the Richmond Index, a stock must have high growth potential and be undervalued as a result of a lack of investor exposure. These stocks tend to rise to their fair market value as a result of the investor exposure that Richmond Index listed companies receive through the internet, and Richmond Club luncheon events.
The Richmond Club members are a mix of investment advisors, fund managers, accredited investors, analysts and members of the media.
Presentations from the January 25, 2017 Richmond Club Meeting
Please note that owing to a technical problem, the audiovisual presentations from the January 25th Richmond Club meeting are not available. However, the hard copies of each company presentation are available below for download. We are also pleased to announce that each company will be returning to an upcoming Richmond Club meeting in order to re-present their company story so we can get them online for you. The revised presentation dates will be posted in 'Upcoming Presentations'.
Presentations from the October 26, 2017 Richmond Club Meeting
Company: Oncolytics Biotech Inc. Symbol: TSX: ONC Length: 00:19:39 Presenter: Dr. Brad Thompson, Chairman, President & CEO Occasion: Richmond Club Lunch, Toronto Oncolytics Biotech Inc. is focused on the development of oncolytic viruses for use […]
Company: DelMar Pharmaceuticals, Inc Symbol: NASDAQ: DMPI Length: 00:26:11 Presenter: Jeffrey Bacha, Chairman Occasion: Richmond Club Lunch, Toronto DelMar Pharmaceuticals, Inc. was founded in 2010 to develop and commercialize proven cancer therapies in new orphan drug […]
Company: Metalla Inc. Symbol: CSE: XBR, OTC: EXCFF, FRK: X9CN Length: 00:17:50 Presenter: Tim Gallagher, Chairman and CEO Occasion: Richmond Club Lunch, Toronto Metalla Inc. is a precious metals royalty and streaming company engaged in the acquisition […]
Company: Lomiko Metals Symbol: TSXV: LMR, OTC: LMRMF Length: 00:18:46 Presenter: Paul Gill, CEO Occasion: Richmond Club Lunch, Toronto Lomiko Metals Inc. is a Canada-based, exploration-stage company. The Company is engaged in the acquisition, exploration […]
Company: VolitionRx Ltd. Symbol: NYSE MKT: VNRX Length: 00:23:42 Presenter: Cameron Reynolds, President and CEO Occasion: Richmond Club Lunch, Toronto VolitionRx’s mission is to address the need for non-invasive, accurate, and cost-effective diagnostics for cancer […]